Amelogénesis imperfecta (AI) is an inherited disorder that affects enamel, characterized by hypomineralization or hypoplasia with discoloration, sensitivity and fragility. Report an uncooperative female patient aged five is taken to the emergency Cayetano Heredia Dental Clinic because of pain. During the anamnesis the parent revealed his second son had the same condition as his younger daughter.Clinical and radiographic evaluation the patient presented: multiple cavitated lesions, necrotic pulp and enamel hypoplasia. Through these tests a presumptive diagnosis enamel defect: Amelogenesis Imperfecta was reached. The clinic advised the parent of the various treatment available, the parent opted for a comprehensive treatment under general anesthesia; having extracted the workpiece 75, aspartame ́s of the treatment, The extracted tooth was taken to pathology services for analysis. Diagnosi...

Amelogénesis imperfecta (AI) is an inherited disorder that affects enamel, characterized by hypomineralization or hypoplasia with discoloration, sensitivity and fragility. Report an uncooperative female patient aged five is taken to the emergency Cayetano Heredia Dental Clinic because of pain. During the anamnesis the parent revealed his second son had the same condition as his younger daughter.Clinical and radiographic evaluation the patient presented: multiple cavitated lesions, necrotic pulp and enamel hypoplasia. Through these tests a presumptive diagnosis enamel defect: Amelogenesis Imperfecta was reached. The clinic advised the parent of the various treatment available, the parent opted for a comprehensive treatment under general anesthesia; having extracted the workpiece 75, aspartame ́s of the treatment, The extracted tooth was taken to pathology services for analysis. Diagnosi...

El propósito del presente estudio fue evaluar la efectividad de dos formas de administración demidazolam, vía oral e intranasal en la modificación de la conducta de niños en edad preescolarquienes recibieron tratamiento dental. Participaron 20 niños con edades entre los 22 a 68meses, quienes recibieron midazolam en dosis de 0,5mg/kg de peso administrado por vía oral y0,2 mg/kg de peso administrado por vía intranasal. A todos los niños se les registró la presiónarterial, frecuencia cardiaca y saturación de oxigeno antes, durante y después de la sedación. Seevaluaron los cambios de conducta utilizando la escala de Houpt. Los rangos alcanzados en losparámetros llanto, somnolencia y movimientos no difieren significativamente en ambas vías.Los signos vitales se mantuvieron estables en los tres momentos evaluados para ambas vías(antes, durante y después de la sedación). No s...